Ascletis Pharma Initiates Dosing in Phase I Trial for COVID-19 Treatment ASC11
China-based Ascletis Pharma Inc. (HKG: 1672) has announced the dosing of four healthy subjects in...
Base Therapeutics Secures Series A1 Funding to Advance Gene Editing Pipelines
Base Therapeutics, a Guangdong-based firm specializing in base editing and prime editing technologies, has reportedly...
ConceMed Raises Pre-Series A Funding to Expand Digestive Endoscope Pipeline
ConceMed, a Guangdong-based maker of digestive soft electronic endoscopes, has reportedly raised “tens of millions”...
Luye Pharma’s Rykindo Receives FDA Approval for Schizophrenia and Bipolar I Disorder
China-based Luye Pharma Group (HKG: 2186) has announced receiving market approval from the US Food...
WuXi Biologics CEO Outlines Growth Amid Global Challenges at J.P. Morgan Conference
China-based WuXi Biologics (HKG: 2269) delivered a speech at the J.P. Morgan Healthcare Conference, where...
Hengrui’s Generic Cyclophosphamide Capsules Approved by China’s NMPA
China-based Jiangsu Hengrui Pharmaceuticals (SHA: 600276) has announced receiving marketing approval from the National Medical...
ReLive Biotechnologies Acquires Co.Don AG, Secures USD 36 Million for Expansion
Tissue engineering and regenerative medicine start-up ReLive Biotechnologies Ltd has announced the full acquisition of...
Akeso’s Penpulimab Secures New Approval for Lung Cancer Indication
China-based Akeso Biopharma (HKG: 9926) has announced receiving another indication approval from the National Medical...
Clover Biopharmaceuticals Plans COVID-19 Vaccine SCB-2019 Launch in China for 2023
China-based Clover Biopharmaceuticals, Ltd (HKG: 2197) has provided updates on its plans for the commercialization...
Amoytop’s AK0706 Receives Clinical Trial Approval for Hepatitis B Treatment
Xiamen-based Amoytop Biotech Co. Ltd has announced receiving clinical trial approval from China’s National Medical...
JHM Biopharma Raises RMB100 Million to Expand Protein Drug Pipeline
Hangzhou-based protein drug developer JHM Biopharma has reportedly secured close to RMB100 million (USD14.9 million)...
Sino Biopharma’s PD-L1 Combo with Anlotinib Accepted for Review by China’s CDE
China-based Sino Biopharmaceutical Ltd (HKG: 1177) has announced that its New Drug Application (NDA) filing...
Meheco’s Genertec Partners with AstraZeneca for COVID-19 Antibody Evusheld in China
China Meheco Group Co., Ltd (SHA: 600056) announced that its subsidiary Genertec Meheco has entered...
Guangzhou’s Overseas Pharma Wins China Clinical Trial Approval for OPL-038
Guangzhou-based Overseas Pharmaceuticals, Ltd has secured clinical trial approval in China for its sustained and...
Eyougene Raises Hundreds of Millions in Series B Funding for Expansion
Eyougene Co., Ltd, a digital Contract Development and Manufacturing Organization (CDMO) based in Shanghai, has...
LePure Bio Secures Hundreds of Millions in Series C Funding for Expansion
Shanghai LePure Biotech Co., Ltd, a China-based biotechnology company, has reportedly raised “hundreds of millions”...
Shenzhen Keyto Fluid Control Secures Series C Funding for Expansion
Shenzhen Keyto Fluid Control Co., Ltd, a China-based manufacturer of precision fluid control components, has...
Xinhua Pharma’s OAB-14 Receives NMPA Approval for Phase I Alzheimer’s Study
China-based Shandong Xinhua Pharmaceutical Co., Ltd (SHE: 000756) has announced receiving approval from the National...
Cii Tech Secures Tens of Millions in Pre-Series A Funding for Mass Spectrometry
China Innovation Instrument (Cii Tech), a life sciences instrument maker based in Ningbo, has reportedly...
TechnoDerma Raises Series A+ Funding to Advance Dermatology Pipeline
TechnoDerma Medicines Inc., a Zhejiang-based developer of dermatology small molecules, has reportedly raised “tens of...